|
2024
|
Invention
|
Tie-2 activators targeting the schlemm's canal.
Disclosed herein are compounds effective for act... |
|
2023
|
Invention
|
Multispecific antibodies that target hptp-beta (ve-ptp) and vegf.
The disclosure provides compos... |
|
|
Invention
|
Methods of treating intraocular pressure with activators of tie-2. Disclosed herein are compounds... |
|
|
Invention
|
Continuous dosing regimen for treatment of a condition of the eye.
This invention relates to con... |
|
|
Invention
|
Method of treating wet age-related macular degeneration.
This invention relates to a method of t... |
|
|
Invention
|
Continuous dosing regimen for treatment of a condition of the eye. This invention relates to cont... |
|
|
Invention
|
Method of preventing age-related macular degeneration by administering an ocular drug delivery in... |
|
|
Invention
|
Method of treating wet age-related macular degeneration. This invention relates to a method of tr... |
|
|
Invention
|
Small molecule activators of tie-2. Disclosed herein are compounds effective for activation of Ti... |
|
|
Invention
|
Ocular injector |
|
2022
|
Invention
|
Bioerodible drug delivery devices.
This invention relates to a bioerodible drug delivery device ... |
|
|
Invention
|
Injector for delivering implants. An injector (100) includes a push rod, a magazine tube, a gate,... |
|
|
Invention
|
Injector for delivering implants.
An injector includes a push rod, a magazine tube, a gate, a ca... |
|
|
Invention
|
Formulations of tie-2 activators and methods of use thereof.
Disclosed herein are compounds effe... |
|
|
Invention
|
Method of treating an ocular condition by administering a humanized monoclonal antibodies that ta... |
|
|
Invention
|
Bioerodible drug delivery devices. This invention relates to a bioerodible drug delivery device t... |
|
|
Invention
|
Compositions, formulations and methods for treating ocular diseases. Disclosed herein are compoun... |
|
|
Invention
|
Human protein tyrosine phosphatase inhibitors and methods of use.
The present disclosure relates... |
|
|
Invention
|
Bioerodible ocular drug delivery insert and therapeutic method.
This invention relates to implan... |
|
|
Invention
|
Tie-2 activators targeting the schlemm's canal. Disclosed herein are compounds effective for acti... |
|
2021
|
Invention
|
Methods for manufacture of small molecule activators of tie-2.
Disclosed herein are compounds ef... |
|
|
Invention
|
Methods for manufacture of small molecule activators of tie-2. Disclosed herein are compounds eff... |
|
|
Invention
|
Dosage forms of tie-2 activators. Disclosed herein are compounds and compositions effective for m... |
|
|
Invention
|
Bioerodible ocular drug delivery insert and therapeutic method. This invention relates to implant... |
|
|
Invention
|
Compositions and methods for treating ocular edema, neovascularization and related diseases.
Dis... |
|
|
Invention
|
Methods of treating acute respiratory distress syndrome with activators of tie-2.
Disclosed here... |
|
|
Invention
|
Methods of treating acute respiratory distress syndrome with activators of tie-2. Disclosed herei... |
|
|
Invention
|
Combinations of tie-2 activators and prostaglandins and uses thereof. Described herein are combin... |
|
|
Invention
|
Combinations of tie-2 activators and prostaglandins and uses thereof.
Described herein are combi... |
|
2020
|
Invention
|
Method of treating ocular conditions by administering an antibody that activates tie2 and binds v... |
|
|
Invention
|
Hptp-beta inhibitors.
Disclosed herein are compounds effective for activation of Tie-2 and inhib... |
|
|
Invention
|
Methods for treating vascular leak syndrome and cancer. Disclosed are methods for treating Vascul... |
|
|
Invention
|
Formulations of tie-2 activators and methods of use thereof. Disclosed herein are compounds effec... |
|
|
Invention
|
Compositions, formulations and methods for treating ocular diseases.
Disclosed herein are compou... |
|
|
Invention
|
Methods of treating hypertension with activators of tie-2.
Disclosed herein are methods for trea... |
|
|
Invention
|
Methods of treating hypertension with activators of tie-2. Disclosed herein are methods for treat... |
|
|
Invention
|
Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof. Antibod... |
